Business Context and Reporting Period
Company: HEALTHSOUTH Corporation (Note: Request metadata listed "Encompass Health Corp," but the filing text identifies the registrant as HEALTHSOUTH Corporation).
Reporting Period: Fiscal year ended December 31, 1995.
Business Overview: HEALTHSOUTH is the nation's largest provider of outpatient and rehabilitative healthcare services, operating a national network of rehabilitation facilities, outpatient surgery centers, and medical centers. The company's strategy focuses on an integrated service model, marketing to managed care organizations, and cost-effective service delivery.
Recent Activity: The company pursued an aggressive acquisition strategy in 1995, including the purchase of NovaCare's rehabilitation hospitals, Caremark Orthopedic Services, Surgical Health Corporation (SHC), and Sutter Surgery Centers (SSCI). Two additional major acquisitions (Surgical Care Affiliates and Advantage Health) were consummated in early 1996.
Key Financial Metrics (Year Ended Dec 31, 1995)
| Metric | 1995 Value | 1994 Value |
|---|---|---|
| Revenues | $1,556,687,000 | $1,274,365,000 |
| Net Income | $78,949,000 | $50,493,000 |
| Net Income Per Share (Diluted) | $0.82 | $0.58 |
| Operating Cash Flow | $217,282,000 | $151,826,000 |
| Total Assets | $2,460,129,000 | $1,778,939,000 |
| Long-Term Debt | $1,253,374,000 | $1,032,941,000 |
| Working Capital | $327,474,000 | $236,877,000 |
| Cash & Marketable Securities | $108,973,000 | $90,066,000 |
Revenue Mix (1995): Medicare (40.0%), Commercial (34.8%), Workers' Compensation (10.3%), All Other (14.9%).
Material Changes vs. Prior Period
- Revenue Growth: Revenues increased 22.2% to $1.56 billion, driven by new store revenues ($146.4 million) from acquisitions and a 10.7% increase in same-store revenues.
- Profitability: Net income rose 56.4% to $78.9 million. Operating expenses as a percentage of revenue improved to 72.6% in 1995 from 76.9% in 1994.
- Acquisition Costs: Merger and acquisition-related expenses totaled $34.2 million in 1995, compared to $6.5 million in 1994. This included $14.6 million related to the retirement of SHC notes.
- Asset Impairments: The company recognized an $11.2 million loss on impairment of assets in 1995 related to six SHC facilities, compared to a $10.5 million loss in 1994.
- Debt Levels: Long-term debt increased by approximately $220 million, primarily due to borrowings under a $1 billion revolving credit facility (drawn $790 million at year-end) to fund acquisitions.
Guidance, Outlook, and Risks
Outlook and Capital Allocation: Management anticipates spending approximately $30 million on maintenance/expansion and $150 million on the development of the Integrated Service Model over the next twelve months. The company expects existing cash, operating cash flow, and credit facility borrowings to be sufficient for future requirements.
Key Risks and Contingencies:
- Regulatory Environment: Significant exposure to changes in Medicare reimbursement (Prospective Payment System) and federal/state laws regarding physician referrals (Stark II, Fraud and Abuse Law). The company has restructured partnerships to comply with Stark II but notes ongoing regulatory uncertainty.
- Reimbursement Rates: Increasing pressure from payors to contain costs through negotiated discounts and utilization reviews.
- Integration Risk: The company is integrating numerous acquired facilities (NovaCare, Caremark, SHC, SSCI) and faces risks related to the successful implementation of its Integrated Service Model.
- Legal Proceedings: The company is subject to routine claims and Medicare rate appeals, though management does not believe pending actions will have a material adverse effect.
Investor Verification Checklist
- Acquisition Accounting: Verify the treatment of pooling-of-interests vs. purchase method for the 1995 acquisitions (SHC, SSCI, ReLife vs. NovaCare, Caremark) and the impact on pro forma earnings.
- Debt Covenants: Review the terms of the $1 billion revolving credit facility, specifically the negative pledge on assets and the maturity date (October 1, 2000), and the status of the proposed amendment to extend maturity.
- Regulatory Compliance: Assess the status of the company's restructuring of physician partnerships to comply with Stark II and the potential impact of future interpretations of the Fraud and Abuse Law.
- Asset Quality: Investigate the specific details of the $11.2 million impairment charge related to SHC facilities and the criteria used for future impairment testing.
- Related Party Transactions: Review transactions with Capstone Capital Corporation (property sales/leases) and GG Enterprises (computer equipment purchases) for terms and fairness.